Our study found that Rb1 and TP53 co-mutate in a hypoxic microenvironment, suggesting that Rb1 and TP53 mutational inactivation may cause tumor resistance to ICIs in a hypoxic microenvironment (Ku et al., 2017). The gene discussed is TP53; the disease is neoplasm.